Xilio Therapeutics (XLO) Selling, General & Administrative (2020 - 2026)
Xilio Therapeutics (XLO) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | 2.17 Mn |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 555.10 Mn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 493.70 Mn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | 647.70 Mn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | 17.02 Mn |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | 1.13 Bn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 322.55 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | 101.25 Mn |
| 10 | Xilio Therapeutics | 146.88 Mn | -3.42 Mn | - | 6.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.93 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 7.12 Mn |
| Mar 31, 2025 | 8.52 Mn |
| Dec 31, 2024 | 6.52 Mn |
| Sep 30, 2024 | 6.31 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Mar 31, 2024 | 6.14 Mn |
| Dec 31, 2023 | 6.39 Mn |
| Sep 30, 2023 | 6.31 Mn |
| Jun 30, 2023 | 6.90 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 8.17 Mn |
| Sep 30, 2022 | 7.17 Mn |
| Jun 30, 2022 | 8.31 Mn |
| Mar 31, 2022 | 6.30 Mn |
| Dec 31, 2021 | 8.20 Mn |
| Sep 30, 2021 | 5.49 Mn |
| Jun 30, 2021 | 5.26 Mn |